Abstract:OBJECTIVES:With the decreased protective effect of Bacille Calmette-Guérin (BCG) vaccine, widespread drug-resistant strains of tuberculosis as well as the lack of effective vaccines, global morbidity and mortality of tuberculosis remains high. The purpose of this study is to evaluate the potential of Mycobacterium tuberculosis antigen Rv2654 as a candidate vaccine against tuberculosis, and to verify the characteristics of cellular and humoral immune responses in mice induced by this protein.METHODS:Isopropyl-beta-D-thiogalactoside (IPTG) was added to induce the expression of Rv2654 recombinant protein in the logarithmic growth stage of bacteria. The recombinant protein was purified by affinity chromatography and identified by Western blotting. The immunoreactivity of Rv2654 recombinant protein with human sera was detected by ELISA. After immunization with Rv2654 recombinant protein, the levels of Th1/Th2 cytokines in peripheral blood of mice was measured using cytokine magnetic bead arrays, and the T and B lymphocyte subsets in spleen of mice was analyzed by flow cytometry.RESULTS:The recombinant protein Rv2654 was successfully induced and expressed. The ELISA data showed that the recombinant protein Rv2654 was responsive to the serum of BCG-inoculated patients or active pulmonary tuberculosis patients. In immunized mice with recombinant protein Rv2654, the expression of IFN-γ, TNF-α, IL-2, IL-4, IL-6, IL-10 and other cytokines in peripheral blood was elevated (all P<0.05). Flow cytometry analysis showed that the recombinant protein significantly stimulated the differentiation of CD4+T cells and CD8+T cells into effector T cells, and this effect was more obvious when combined with BCG. The recombinant protein Rv2654 also stimulated the activation and proliferation of B cells and their differentiation into memory cells. However, less plasma cells were produced.CONCLUSIONS:Rv2654 protein could induce the cell immune responses and it has good binding ability with serum of BCG-inoculated patients and active pulmonary tuberculosis patients, suggesting that it may serve as a good candidate antigen for tuberculosis immunological prophylaxis and diagnostic vaccines.

Resuscitation Activity of Recombinant RpfE Protein of Mycobacterium Tuberculosis on Dormant BCG

Expression, Purification and Characterization of Mycobacterium Tuberculosis RpfE Protein

Expression, Purification, and Characterization of Soluble RpfD with High Bioactivity As a Recombinant Protein in Mycobacterium Vaccae.

Bioinformatic Analysis, Cloning and Expression of Rv1009 of Mycobacterium Tuberculosis

Prokaryotic expression and biological activities of the recombinant resuscitation promoting factor-like proteins in Mycobacterium tuberculosis

Cloning and expression of Mycobacterium tuberculosis resuscitation-promoting factor(RPF)

Production and Characterization of Monoclonal Antibody Against Mycobacterium Tuberculosis RpfB Domain.

Expression and Purification of Rv2654 Recombinant Protein from Mycobacterium Tuberculosis and Its Characteristics of Immune Response.

Expression in E. coli and bioactivity assay of Micrococcus luteus resuscitation promoting factor domain and its mutants

Expression, Identification and Purification of RpfA Protein from Mycobacterium Tuberculosis

Expression,Purification and Identification of the Mycobacterium Tuberculosis Protein Latency Antigen Rv1733c

Recombinant protein Rv2346c inhibits the immunological response of macrophage against Mycobacterium tuberculosis

Prokaryotic Expression of Resuscitation-promoting Factor-interacting Protein A and Determination of Its Resuscitation Activity on the Mycobacterium Smegmatis

Enzymatic properties and biological activity of resuscitation-promoting factor B of Rhodococcus sp. (GX12401)

Effects of Micrococcus Luteus Rpf and Rpf Domain Protein on Growth of Mycobacterium Tuberculosis

[Expression and Purification of Rv3369 of Mycobacterium Tuberculosis].

Subunit Vaccines Consisting of Antigens from Dormant and Replicating Bacteria Show Promising Therapeutic Effect Against Mycobacterium Bovis BCG Latent Infection

The Cloning,Expression,Purification and Antigenicity of Rv2461c of Mycobacterium Tuberculosis

Recombinant Expression, Purification and Identification of Antigen Rv0309 of Mycobacterium Tuberculosis

Recombinant Expression,Purification and Identification of Antigen Rv0173 of Mycobacterium Tuberculosis(mtb.)

Protein-protein interaction between Rv 3425 and Rv3614c in Mycobacterium tuberculosis